Embodiments of the present disclosure relate to vision treatment techniques and in particular, to ophthalmic lenses such as, for example, contact lenses, corneal inlays or onlays, or intraocular lenses (IOLs) including, for example, phakic IOLs and piggyback IOLs (i.e. IOLs implanted in an eye already having an IOL).
Presbyopia is a condition that affects the accommodation properties of the eye. As objects move closer to a young, properly functioning eye, the effects of ciliary muscle contraction and zonular relaxation allow the lens of the eye to change shape, and thus increase its optical power and ability to focus at near distances. This accommodation can allow the eye to focus and refocus between near and far objects.
Presbyopia normally develops as a person ages and is associated with a natural progressive loss of accommodation. The presbyopic eye often loses the ability to rapidly and easily refocus on objects at varying distances. The effects of presbyopia usually become noticeable after the age of 45 years. By the age of 65 years, the crystalline lens has often lost almost all elastic properties and has only a limited ability to change shape.
Along with reductions in accommodation of the eye, age may also induce clouding of the lens due to the formation of a cataract. A cataract may form in the hard central nucleus of the lens, in the softer peripheral cortical portion of the lens, or at the back of the lens. Cataracts can be treated by the replacement of the cloudy natural lens with an artificial lens. An artificial lens replaces the natural lens in the eye, with the artificial lens often being referred to as an intraocular lens or “IOL.”
Monofocal IOLs are intended to provide vision correction at one distance only, usually the far focus. At the very least, since a monofocal IOL provides vision treatment at only one distance and since the typical correction is for far distance, spectacles are usually needed for good vision at near distances and sometimes for good vision at intermediate distances. The term “near vision” generally corresponds to vision provided when objects are at a distance from the subject eye at equal; or less than 1.5 feet. The term “distant vision” generally corresponds to vision provided when objects are at a distance of at least ab out 5-6 feet or greater. The term “intermediate vision” corresponds to vision provided when objects are at a distance of about 1.5 feet to about 5-6 feet from the subject eye. Such characterizations of near, intermediate, and far vision correspond to those addressed in Morlock R, Wirth R J, Tally S R, Garufis C, Heichel C W D, Patient-Reported Spectacle Independence Questionnaire (PRSIQ): Development and Validation. Am J Ophthalmology 2017; 178:101-114.
There have been various attempts to address limitations associated with monofocal IOLs. For example, multifocal IOLs have been proposed that deliver, in principle, two foci, one near and one far, optionally with some degree of intermediate focus. Such multifocal, or bifocal, IOLs are intended to provide good vision at two distances, and include both refractive and diffractive multifocal IOLs. In some instances, a multifocal IOL intended to correct vision at two distances may provide a near (add) power of about 3.0 or 4.0 diopters.
Multifocal IOLs may, for example, rely on a diffractive optical surface to direct portions of the light energy toward differing focal distances, thereby allowing the patient to clearly see both near and far objects. Multifocal ophthalmic lenses (including contact lenses or the like) have also been proposed for treatment of presbyopia without removal of the natural crystalline lens. Diffractive optical surfaces, either monofocal or multifocal, may also be configured to provide reduced chromatic aberration.
Diffractive monofocal and multifocal lenses can make use of a material having a given refractive index and a surface curvature which provide a refractive power. Diffractive lenses have a diffractive profile which confers the lens with a diffractive power that contributes to the overall optical power of the lens. The diffractive profile is typically characterized by a number of diffractive zones. When used for ophthalmic lenses these zones are typically annular lens zones, or echelettes, spaced aboutthe optical axis of the lens. Each echelette may be defined by an optical zone, a transition zone between the optical zone and an optical zone of an adjacent echelette, and an echelette geometry. The echelette geometry includes an inner and outer diameter and a shape or slope of the optical zone, a height or step height, and a shape of the transition zone. The surface area or diameter of the echelettes largely determines the diffractive power(s) of the lens and the step height of the transition between echelettes largely determines the light distribution between the different powers. Together, these echelettes form a diffractive profile.
A multifocal diffractive profile of the lens may be used to mitigate presbyopia by providing two or more optical powers; for example, one for near vision and one for far vision. The lenses may also take the form of an intraocular lens placed within the capsular bag of the eye, replacing the original lens, or placed in front of the natural crystalline lens. The lenses may also be in the form of a contact lens, most commonly a bifocal contact lens, or in any other form mentioned herein.
Although multifocal ophthalmic lenses lead to improved quality of vision for many patients, additional improvements would be beneficial. For example, some pseudophakic patients experience undesirable visual effects (dysphotopsia), e.g. glare or halos. Halos may arise when light from the unused focal image creates an out-of-focus image that is superimposed on the used focal image. For example, if light from a distant point source is imaged onto the retina by the distant focus of a bifocal IOL, the near focus of the IOL will simultaneously superimpose a defocused image on top of the image formed by the distant focus. This defocused image may manifest itself in the form of a ring of light surrounding the in-focus image, and is referred to as a halo. Another area of improvement revolves around the typical bifocality of multifocal lenses. While multifocal ophthalmic lenses typically provide adequate near and far vision, intermediate vision may be compromised.
A lens with an extended range of vision may thus provide certain patients the benefits of good vision at a range of distances, while having reduced or no dysphotopsia. Various techniques for extending the depth of focus of an IOL have been proposed. One technique is embodied in the Tecnis Symfony® lens offered by Johnson& Johnson Vision. One technique may include a bulls-eye refractive principle, and may involve a central zone with a slightly increased power. One technique may include an asphere or include refractive zones with different refractive zonal powers.
Although certain proposed treatments may provide some benefit to patients in need thereof, further advances would be desirable. For example, it would be desirable to provide improved IOL systems and methods that confer enhanced image quality across a wide and extended range of foci without dysphotopsia. Embodiments of the present disclosure provide solutions that may address the problems described above, and hence may provide answers to at least some of these outstanding needs.
Embodiments herein described include ophthalmic lenses including an optic. The optic may include a diffractive profile including at least one set of echelettes, each echelette of the set having a different width in r-squared space than any other echelette of the set and the at least one set of echelettes repeating at least once upon the optic.
Embodiments herein described include a method comprising fabricating an optic for an ophthalmic lens, the optic including a diffractive profile including at least one set of echelettes, each echelette of the set having a different width in r-squared space than any other echelette of the set and the at least one set of echelettes repeating at least once upon the optic.
Embodiments herein described include a system for fabricating an ophthalmic lens. The system may include a processor configured to determine a diffractive profile of an optic, the diffractive profile including at least one set of echelettes, each echelette ofthe set having a different width in r-squared space than any other echelette of the set and the at least one set of echelettes repeating at least once upon the optic. The system may include a manufacturing assembly that fabricates the optic based on the diffractive profile.
Embodiments herein described include ophthalmic lenses including an optic. The optic may include a diffractive profile including a plurality of echelettes, at least one echelette of the diffractive profile having a same width in r-squared space as another echelette of the diffractive profile, and at least one echelette of the diffractive profile having a different width in r-squared space than any other echelette of the diffractive profile.
Embodiments herein described include a method comprising fabricating an optic for an ophthalmic lens, the optic including a diffractive profile including a plurality of echelettes, at least one echelette of the diffractive profile having a same width in r-squared space as another echelette of the diffractive profile, and at least one echelette of the diffractive profile having a different width in r-squared space than any other echelette of the diffractive profile.
Embodiments herein described include a system for fabricating an ophthalmic lens. The system may include a processor configured to determine a diffractive profile of an optic, the diffractive profile including a plurality of echelettes, at least one echelette of the diffractive profile having a same width in r-squared space as another echelette of the diffractive profile, and at least one echelette of the diffractive profile having a different width in r-squared space than any other echelette of the diffractive profile. The system may include a manufacturing assembly that fabricates the optic based on the diffractive profile.
Embodiments herein described include ophthalmic lenses including an optic. The optic may include a diffractive profile including at least one echelette having a power and having a different width in r-squared space than another echelette of the diffractive profile, the at least one echelette being configured to distribute light to a distance focus.
The optic may include a refractive profile having a refractive zone with a width corresponding to the width of the at least one echelette and having a power that is negative or positive with respect to the power of the at least one echelette, the refractive zone configured to vary the distance focus of the at least one echelette.
Embodiments herein described include a method comprising fabricating an optic for an ophthalmic lens. The optic may include a diffractive profile including at least one echelette having a power and having a different width in r-squared space than another echelette of the diffractive profile, the at least one echelette being configured to distribute light to a distance focus.
The optic may include a refractive profile having a refractive zone with a width corresponding to the width of the at least one echelette and having a power that is negative or positive with respect to the power of the at least one echelette, the refractive zone configured to vary the distance focus of the at least one echelette.
Embodiments herein described include a system for fabricating an ophthalmic lens. The system may include a processor configured to determine a diffractive profile and a refractive profile of an optic, the diffractive profile including at least one echelette having a power and having a different width in r-squared space than another echelette of the diffractive profile, the at least one echelette being configured to distribute light to a distance focus, and the refractive profile having a refractive zone with a width corresponding to the width of the at least one echelette and having a power that is negative or positive with respect to the power of the at least one echelette, the refractive zone configured to vary the distance focus of the at least one echelette.
The system may include a manufacturing assembly that fabricates the optic based on the diffractive profile and the refractive profile.
Embodiments herein described include ophthalmic lenses including an optic. The optic including a diffractive profile including a plurality of echelettes, each echelette of the diffractive profile having a different width in r-squared space than any other echelette of the diffractive profile.
Embodiments herein described include a method comprising fabricating an optic for an ophthalmic lens, the optic including a diffractive profile including a plurality of echelettes, each echelette of the diffractive profile having a different width in r-squared space than any other echelette of the diffractive profile.
Embodiments herein described include a system for fabricating an ophthalmic lens. The system may include a processor configured to determine a diffractive profile of an optic, the diffractive profile including a plurality of echelettes, each echelette of the diffractive profile having a different width in r-squared space than any other echelette of the diffractive profile. The system may include a manufacturing assembly that fabricates the optic based on the diffractive profile.
Each major face of lens 11, including the anterior (front) surface and posterior (back) surface, generally has a refractive profile, e.g. biconvex, plano-convex, plano-concave, meniscus, etc. The two surfaces together, in relation to the properties of the surrounding aqueous humor, cornea, and other optical components of the overall optical system, define the effects of the lens 11 on the imaging performance by eye E. Conventional, monofocal IOLs have a refractive power based on the refractive index of the material from which the lens is made, and also on the curvature or shape of the front and rear surfaces or faces of the lens. One or more support elements may be configured to secure the lens 11 to a patient's eye.
Multifocal lenses may optionally also make special use of the refractive properties of the lens. Such lenses generally include different powers in different regions of the lens so as to mitigate the effects of presbyopia. For example, as shown in
Rather than relying entirely on the refractive properties of the lens, multifocal diffractive IOLs or contact lenses can also have a diffractive power, as illustrated by the IOL 18 shown in
The diffractive profile of a diffractive multifocal lens directs incoming light into a number of diffraction orders. As light 13 enters from the front of the eye, the multifocal lens 18 directs light 13 to form a far field focus 15a on retina 16 for viewing distant objects and a near field focus 15b for viewing objects close to the eye. Depending on the distance from the source of light 13, the focus on retina 16 may be the near field focus 15b instead. Typically, far field focus 15a is associated with 0th diffractive order and near field focus 15b is associated with the 1st diffractive order, although other orders may be used as well.
Bifocal ophthalmic lens 18 typically distributes the majority of light energy into two viewing orders, often with the goal of splitting imaging light energy about evenly (50%:50%), one viewing order corresponding to far vision and one viewing order corresponding to near vision, although typically, some fraction goes to non-viewing orders.
Corrective optics may be provided by phakic IOLs, which can be used to treat patients while leaving the natural lens in place. Phakic IOLs may be angle supported, iris supported, or sulcus supported. The phakic IOL can be placed over the natural crystalline lens or piggy-backed over another IOL. It is also envisioned that the present disclosure may be applied to inlays, onlays, accommodating IOLs, pseudophakic IOLs, other forms of intraocular implants, spectacles, and even laser vision correction.
When fitted onto the eye of a subject or patient, the optical axis of lens 20 is generally aligned with the optical axis of eye E. The curvature of lens 20 gives lens 20 an anterior refractive profile and a posterior refractive profile. Although a diffractive profile may also be imposed on either anterior face 21 and posterior face 22 or both,
Conventional multifocal diffractive lenses typically provide for near and far vision, neglecting visual performance at intermediate distances.
The diffractive profile 400 includes a plurality of echelettes (representative echelettes 408a, 408b, 408c are marked) that each have the same width in r-squared space. The step height of each echelette is also the same in the diffractive profile 400. The diffractive pattern accordingly may direct light to two focuses (forming a bifocal optic).
The diffractive profile 500 includes a plurality of echelettes. The echelettes are provided as repeating set of two different echelettes, with one configuration of echelette being marked in
The optic represented in
In the embodiment of
Each echelette 702a-d may be positioned on a surface of the optic, with the surface extending radially outward from the optical axis 704 to the outer periphery of the optic (such as the outer periphery 27 marked in
The different widths in r-squared space of the echelettes 702a-d may correspond to different diffractive or add powers of the optic. The echelette 702b for example, may correspond to a diffractive or add power of 3 diopter, for example. The echelette 702c for example, may correspond to a diffractive or add power of 2.4 diopter, for example. The echelette 702d for example, may correspond to a diffractive or add power of 1.8 diopter, for example. The corresponding diffractive or add power may be different for each echelette 702a-d. Various other diffractive or add powers may be utilized as desired.
In embodiments, the echelettes 702a-d may each distribute some light to a distance focus, to provide a smooth, extended depth of focus or extended range of vision for the individual, decreased visual symptoms, and improved distance vision. Further, at least one of the echelettes 702a-d may be configured to distribute light to a near focus or to an intermediate focus. In embodiments, the echelettes 702a-d may be configured to split light to both a distance focus and a near focus, or to a distance focus, an intermediate focus, and/or a near focus.
The irregular width of the echelettes 702a-d may provide a smooth, extended depth of focus or extended range of vision for the individual and may break the symmetry between the r-squared distances of transition zones between the echelettes, thus reducing undesired visual symptoms. The diffractive profile may form an extended depth of focus. The diffractive profile may also modify chromatic aberration in a distance focus. Combinations of features may be provided as desired.
One or more of the echelettes 702a-d may have the same step height as each other. For example, as shown in
In one embodiment, the diffractive profile 700 may include a plurality of echelettes 702a-d disposed on a surface of the optic such that each one of the plurality of echelettes 702a-d between the optical axis and the outer periphery of the optic has a different width in r-squared space than any other echelette on the surface of the optic between the optical axis and the outer periphery of the optic.
In one embodiment, the echelettes 702a-d of the diffractive profile 700 may be positioned in a central zone 710, that the optical axis 704 may pass through. The optic may include a peripheral zone 712 positioned radially outward of the central zone 710, which may not include a diffractive profile in certain embodiments. The peripheral zone 712 as shown in
The number of echelettes of the diffractive profile 700 may vary. For example, the number may include two echelettes. The number may include at least three echelettes. The number may include at least four echelettes. The number may include at least five echelettes. A greater or lesser number of echelettes may be utilized as desired. In each embodiment, a step height of at least two of the echelettes may be the same, or a step height of at least two of the echelettes may be different.
In embodiments, a diffractive profile may include at least one set of echelettes, with each echelette of the set having a different width in r-squared space than any other echelette of the set. In embodiments, the at least one set may repeat at least once upon the optic.
The diffractive profile 800 includes at least one set 804 of echelettes 806a-d. The echelettes 806a-d of the set 804 each have a different width in r-squared space than any other echelette of the set 804. The set 804 includes four echelettes 806a-d, however, in embodiments, the set may include a greater or lesser number of echelettes. For example, the set 804 may include two echelettes, three echelettes, four echelettes, five echelettes, or may include at least two, at least three, at least four, at least five echelettes, etc. as desired.
The echelettes 806a-d of the set 804 are shown relative to the Y axis 808, which represents the phase shift of the diffractive profile 800. The height or phase shift of the diffractive profile 800 is shown in relation to the radius on the X axis 810 from the optical axis 812 in r-squared space. The radial coordinate represents the distance from the optical axis 812 in r-squared space, and is shown in units of millimeters squared, although in other embodiments, other units or scalings may be utilized.
Each echelette 806a-d may be positioned on a surface of the optic, with the surface extending radially outward from the optical axis 812 to the outer periphery of the optic (such as the outer periphery 27 marked in
Each echelette 806a-d of the set 804 may have a different step height and step offset as shown in
The set 804 may be positioned ata central zone 814 of the optic, or may be positioned at a different location as desired. For example, in embodiments, the set 804 may be at a distance from the optical axis 812 and may be in an intermediate zone or peripheral zone of the optic in embodiments. In embodiments, a peripheral zone may be provided that may include a refractive surface. In embodiments, the central zone 814 may include a refractive surface that is positioned radially inward of the diffractive profile. The optic may include a refractive surface that may provide one or more of an intermediate focus, a near focus, or an extended depth of focus.
The set 804 may repeat upon the optic at least once. In the embodiment shown in
In embodiments, the set 804 may repeat more than once upon the optic. For example, the set 804 may repeat twice upon the optic, or at least twice upon the optic in embodiments (e.g, three times, four times, etc.). The set 804 may repeat at least three times upon the optic, or at least four times, etc. In embodiments, the set 804 may repeat along an entire pupillary zone of the optic, comprisingthe portion of the optic exposed to light through the patient's pupil. The pupillary zone may extend outward from the optical axis 812 towards the outer periphery of the optic. The set 804 may be repeated a desired number of times to cover the entire pupillary zone in embodiments as desired. In other embodiments, only a portion of the optic or the pupillary zone may include a repeating set of echelettes.
The optic may include a single repeating set of echelettes, or may include multiple different sets of echelettes that repeat. In embodiments, each echelette of the respective set may have a different width in r-squared space than any other echelette of that set. In embodiments, the set may not repeat upon the optic. For example,
In an embodiment as shown in
The repeating set of echelettes, as shown in
In embodiments, a diffractive profile may result in correction of chromatic aberration. A diffractive profile may inherently compensate partially or fully for a longitudinal chromatic aberration of the eye. Correction of chromatic aberration may occur by having a diffractive profile with a step size of 1 wavelength or higher. This may occur in monofocal, multifocal, or extended depth of focus lenses.
An aperiodic diffractive profile, as shown in
In embodiments, a diffractive profile may be provided that may include a plurality of echelettes, with at least one echelette of the diffractive profile having a same width in r-squared space as another echelette of the diffractive profile, and at least one echelette of the diffractive profile having a different width in r-squared space than any other echelette of the diffractive profile.
The echelette 1002a has a same width in r-squared space than other echelettes 1002b, c, d-g of the profile 1000, yet has a different width than the echelette 1002h. Thus, in embodiments, at least one echelette 1002h may have a different width in r-squared space than any other echelette of the profile 1000, with the remaining echelettes 1002a-c, d-g each having the same with in r-squared space. Various other modifications may be provided (e.g., at least two echelettes may have a different width in r-squared space than any other echelette of the diffractive profile, at least three, at least four, etc.). Further, the number of echelettes that have a same width in r-squared space may be varied in embodiments as desired, for example, two echelettes of the diffractive profile may have a same width in r-squared space as each other, at least three, at least four, etc.
The total number of echelettes of the diffractive profile 1000 may be varied as desired. For example, in embodiments, the plurality of echelettes of the diffractive profile 1000 may include at least three echelettes, at least four echelettes, at least five echelettes, etc. Eight echelettes are shown as marked in
Features of other embodiments disclosed herein may be utilized with the diffractive profile. For example, at least one echelette of the diffractive profile may be configured to distribute light to a distance focus. In embodiments, at least one echelette of the diffractive profile may be configured to distribute light to a near focus or to an intermediate focus. The diffractive profile may form an extended depth of focus. The diffractive profile may also modify chromatic aberration in a distance focus. Combinations of features may be provided as desired.
Other features may be utilized with the diffractive profile. For example, the diffractive profile 1000 may be disposed on a first surface of an optic such that at least one echelette of the diffractive profile on the first surface between the optical axis and the outer periphery of the optic has a same width in r-squared space as another echelette of the diffractive profile on the first surface between the optical axis and the outer periphery of the optic. At least one echelette of the diffractive profile on the first surface between the optical axis and the outer periphery of the optic may have a different width in r-squared space than any other echelette of the diffractive profile on the first surface between the optical axis and the outer periphery of the optic. The optic may include a central zone and a peripheral zone, and the diffractive profile may be positioned on the central zone, and the peripheral zone may include a refractive surface. A refractive surface as disclosed herein may provide one or more of an intermediate focus, a near focus, or an extended depth of focus.
In embodiments, a central zone may include a refractive surface that is positioned radially inward of the diffractive profile 1000. Various other modifications and combinations of features across embodiments may be provided as desired.
In embodiments, to receive benefits of correction of longitudinal chromatic aberration provided by an aperiodic diffractive profile, yet to have the echelettes of the diffractive profile direct light to the same distance foci, a refractive profile may be utilized to vary a distance focus of the echelettes of the diffractive profile. The diffractive profile may include at least one echelette having a power and having a different width in r-squared space than another echelette of the diffractive profile, and being configured to distribute light to a distance focus. The refractive profile may have a refractive zone with a width corresponding to a width of the at least one echelette and having a power that is negative or positive with respect to the power of the at least one echelette, and configured to vary a distance focus of the at least one echelette.
The diffractive profile 1200 may be configured in embodiments such that the echelettes 1204a-c each have corresponding diffractive powers between 1 and 2 diopters. In embodiments, other powers may be utilized for the echelettes 1204a-c. For example, in embodiments the corresponding diffractive powers may be between 1 and 3 diopters, or other powers as desired.
The refractive profile 1202 may be a multi-zonal profile and may include a plurality of refractive zones 1206a-c. Each refractive zone 1206a-c may have a width that corresponds to the width of a respective one of the echelettes 1204a-c, and may match the width as shown in
Each refractive zone 1206a-c may vary the distance focus of the corresponding echelette 1204a-c. In this manner, the correction of longitudinal chromatic aberration provided by the aperiodic diffractive profile 1200 may be achieved, while the distance focus of the echelettes 1204a-c may be the same.
Further, in embodiments herein in which a set of echelettes 1204a-c repeats, the refractive zones of the refractive profile 1202 may repeat, corresponding to the repeating echelettes 1204a-c of the diffractive profile 1200.
In some embodiments, the refractive profile 1202 may be positioned on an opposite optical surface of the optic, with each zone of the refractive profile 1202 positioned optically aligned with a corresponding one of the echelettes 1204a-c. In other embodiments, the refractive profile 1202 may be positioned on the same optical surface as the diffractive profile 1200.
The diffractive profile 1200 and refractive profile 1202 may extend along the optic from the optical axis outward, and may cover the entire pupillary zone of the optic. The optic may have a spatially varying amount of chromatic aberration correction, and may have an amount of longitudinal chromatic aberration correction that differs spatially from the optical axis outward towards the outer periphery of the optic. The amount of longitudinal chromatic aberration may differ over the pupil.
In embodiments, the diffractive profile and refractive profile may cover only a portion of the pupillary zone of the optic. For example, in an embodiment including a diffractive profile 700 such as shown in
In embodiments, utilizing a multizonal refractive profile as disclosed may improve distance modulation transfer function (MTF) by, e.g., 15% for a 3 millimeter pupil and 30% for a 5 millimeter pupil, if diffractive powers of the diffractive profile 1200 are in the range of 1-3 diopter.
The optical or clinical behavior of the embodiments enclosed herein may characterized by a multifocal behavior or by and extended depth of focus behavior, or by a combination thereof. In all of these cases, the embodiments provide patients with an extended range of vision, being larger than that obtain with standard monofocal lenses.
In embodiments, longitudinal chromatic aberration may be reduced by combining two lens materials having different Abbe numbers. Such a doublet may be combined with an aperiodic diffractive profile as disclosed herein.
An optic for an ophthalmic lens that includes a diffractive profile or refractive profile disclosed herein may be fabricated utilizing a variety of methods. A method may include determining optical aberrations of a patient's eye. Measurements of a patient's eye may be made in a clinical setting, such as by an optometrist, ophthalmologist, or other medical or optical professional. The measurements may be made via manifest refraction, autorefraction, tomography, or a combination of these methods or other measurement methods. The optical aberrations of the patient's eye may be determined.
A determination of the visual range of the patient may also be determined. For example, the ability of the patient to focus on near objects (presbyopia) may be measured and determined. A range of corresponding diffractive powers for the ophthalmic lens may be determined.
The measurements of the patient's eye may be placed in an ophthalmic lens prescription, which includes features of an optic that are intended to address the optical aberrations of the patient's eye, as well as features that address the visual range for the patient (e.g., an amount of corresponding diffractive power, a number of focuses, or a range of vision to be provided by the optic).
The ophthalmic lens prescription may be utilized to fabricate an optic for the ophthalmic lens. A refractive profile of the optic may be determined based on the ophthalmic lens prescription, to correct for the optical aberrations of the patient's eye. Such a refractive profile may be applied to the optic, whether on a surface including the diffractive profile or on an opposite optical surface. The diffractive profile may also be determined to provide for the desired distribution of corresponding diffractive powers for the optic.
The determination of one or more of a refractive or diffractive profile and the fabrication of the optic may be performed remotely from the optometrist, ophthalmologist, or other medical or optical professional that performed the measurements of a patient's eye, or may be performed in the same clinical facility of such an individual. If performed remotely, the fabricated optic may be delivered to an optometrist, ophthalmologist, or other medical or optical professional, for being provided to a patient. For an intraocular lens, the fabricated optic may be provided for implant into a patient's eye.
The fabricated optic may be a custom optic fabricated specifically for the patient's eye, or may be fabricated in a manufacturing assembly and then selected by an optometrist, ophthalmologist, or other medical or optical professional for supply to a patient, which may include implantation in the patient's eye.
The processor 1302 may comprise a central processing unit (CPU) or other form of processor. In certain embodiments the processor 1302 may comprise one or more processors. The processor 1302 may include one or more processors that are distributed in certain embodiments, for example, the processor 1302 may be positioned remote from other components of the system 1300 or may be utilized in a cloud computing environment. The memory 1306 may comprise a memory that is readable by the processor 1302. The memory 1306 may store instructions, or features of intraocular lenses, or other parameters that may be utilized by the processor 1302 to perform the methods disclosed herein. The memory 1306 may comprise a hard disk, read-only memory (ROM), random access memory (RAM) or other form of non-transient medium for storing data. The input 1304 may comprise a port, terminal, physical input device, or other form of input. The port or terminal may comprise a physical port or terminal or an electronic port or terminal. The port may comprise a wired or wireless communication device in certain embodiments. The physical input device may comprise a keyboard, touchscreen, keypad, pointer device, or other form of physical input device. The input 1304 may be configured to provide an input to the processor 1302.
The system 1300 may be utilized to perform the methods disclosed herein, such as the processes of determining a diffractive profile of the optic, as well as a refractive profile of the optic. The processor 1302 may be configured to determine the diffractive profile to provide for various corresponding diffractive powers for the optic, as well as determining a refractive profile to correct for ocular aberrations of the patient.
The processor 1302 may provide the refractive profile and/or diffractive profile to the manufacturing assembly 1308, which may be configured to fabricate the optic for the ophthalmic lens based on the refractive profile and/or diffractive profile. The manufacturing assembly 1308 may comprise one or more apparatuses for forming the optic, and may comprise a high volume manufacturing assembly or a low volume manufacturing assembly. The manufacturing assembly 1308 may be used for manufacture remote to a clinic in which measurements of the individual's eye or made, or local to such a clinic. The manufacturing assembly may include apparatuses such as lathe tools, or other lens formation devices to fabricate the optic.
In one embodiment, the processor 1302 may be provided with an ophthalmic lens prescription for the individual's eye that may be provided as discussed herein. The processor 1302 may receive the ophthalmic lens via the input 1304. The system 1300 may fabricate the optic for the ophthalmic lens based on the prescription.
The system 1300 may be configured to fabricate any of the embodiments of ophthalmic lenses disclosed herein.
In one embodiment, a diffractive profile such as the profile 700, profile 800, profile 1000, profile 1100, or profile 1200 may be positioned on a surface of a lens that is opposite an aspheric surface. The aspheric surface on the opposite side of the lens may be designed to reduce comeal spherical aberration of the patient.
In one embodiment, one or both surfaces of the lens may be aspherical, or include a refractive surface designed to extend the depth of focus, or create multifocality.
In one embodiment, a refractive zone on one or both surfaces of the lens may be utilized that may be the same size or different in size as one of the diffractive zones. The refractive zone includes a refractive surface designed to extend the depth of focus, or create multifocality.
Any of the embodiments of lens profiles discussed herein may be apodized to produce a desired result. The apodization may result in the step heights and step offsets of the echelettes being gradually varied according to the apodization, as to gradually increasing the amount of light in the distance focus as a function of pupil diameter.
The features of the optics disclosed herein may be utilized by themselves, or in combination with refractive profiles of the optics and/or with features providing for correction of chromatic aberrations (e.g., achromats, which may be diffractive).
The ophthalmic lenses disclosed herein in the form of intraocular lenses are not limited to lenses for placement in the individual's capsular bag. For example, the intraocular lenses may comprise those positioned within the anterior chamber of the eye. In certain embodiments the intraocular lenses may comprise “piggy back” lenses or other forms of supplemental intraocular lenses.
Features of embodiments may be modified, substituted, excluded, or combined as desired.
In addition, the methods herein are not limited to the methods specifically described, and may include methods of utilizing the systems and apparatuses disclosed herein.
In closing, it is to be understood that although aspects of the present specification are highlighted by referring to specific embodiments, one skilled in the art will readily appreciate that these disclosed embodiments are only illustrative of the principles of the subject matter disclosed herein. Therefore, it should be understood that the disclosed subject matter is in no way limited to a particular methodology, protocol, and/or reagent, etc., described herein. As such, various modifications or changes to or alternative configurations of the disclosed subject matter can be made in accordance with the teachings herein without departing from the spirit of the present specification. Lastly, the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to limit the scope of systems, apparatuses, and methods as disclosed herein, which is defined solely by the claims. Accordingly, the systems, apparatuses, and methods are not limited to that precisely as shown and described.
Certain embodiments of systems, apparatuses, and methods are described herein, including the best mode known to the inventors for carrying out the same. Of course, variations on these described embodiments will become apparent to those of ordinary skill in the art upon reading the foregoing description. The inventor expects skilled artisans to employ such variations as appropriate, and the inventors intend for the systems, apparatuses, and methods to be practiced otherwise than specifically described herein. Accordingly, the systems, apparatuses, and methods include all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described embodiments in all possible variations thereof is encompassed by the systems, apparatuses, and methods unless otherwise indicated herein or otherwise clearly contradicted by context.
Groupings of alternative embodiments, elements, or steps of the systems, apparatuses, and methods are not to be construed as limitations. Each group member may be referred to and claimed individually or in any combination with other group members disclosed herein. It is anticipated that one or more members of a group may be included in, or deleted from, a group for reasons of convenience and/or patentability. When any such inclusion or deletion occurs, the specification is deemed to contain the group as modified thus fulfilling the written description of all Markush groups used in the appended claims.
The terms “a,” “an,” “the” and similar referents used in the context of describing the systems, apparatuses, and methods (especially in the context of the following claims) are to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”) provided herein is intended merely to better illuminate the systems, apparatuses, and methods and does not pose a limitation on the scope of the systems, apparatuses, and methods otherwise claimed. No language in the present specification should be construed as indicating any non-claimed element essential to the practice of the systems, apparatuses, and methods.
All patents, patent publications, and other publications referenced and identified in the present specification are individually and expressly incorporated herein by reference in their entirety for the purpose of describing and disclosing, for example, the compositions and methodologies described in such publications that might be used in connection with the systems, apparatuses, and methods. These publications are provided solely for their disclosure prior to the filing date of the present application. Nothing in this regard should be construed as an admission that the inventors are not entitled to antedate such disclosure by virtue of prior invention or for any other reason. All statements as to the date or representation as to the contents of these documents is based on the information available to the applicants and does not constitute any admission as to the correctness of the dates or contents of these documents.
The present application claims priority to U.S. Provisional Patent Application No. 62/955,355, filed on Dec. 30, 2019, the entire contents of which are incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
3367734 | Karl et al. | Feb 1968 | A |
3722986 | Tagnon | Mar 1973 | A |
4210391 | Cohen et al. | Jul 1980 | A |
4340283 | Cohen | Jul 1982 | A |
4460275 | Spriggs | Jul 1984 | A |
4504892 | Zulfilar | Mar 1985 | A |
4504982 | Burk | Mar 1985 | A |
4580883 | Shinohara | Apr 1986 | A |
4606626 | Shinohara | Aug 1986 | A |
4637697 | Freeman | Jan 1987 | A |
4640593 | Shinohara | Feb 1987 | A |
4641934 | Freeman | Feb 1987 | A |
4642112 | Freeman | Feb 1987 | A |
4655565 | Freeman | Apr 1987 | A |
4710193 | Volk | Dec 1987 | A |
4762408 | Shinohara | Aug 1988 | A |
4778462 | Grendahl | Oct 1988 | A |
4795462 | Grendahl | Jan 1989 | A |
4798608 | Grendahl | Jan 1989 | A |
4798609 | Grendahl | Jan 1989 | A |
4856234 | Goins | Aug 1989 | A |
4856889 | Guilino et al. | Aug 1989 | A |
4881804 | Cohen | Nov 1989 | A |
4881805 | Cohen | Nov 1989 | A |
4898461 | Portney | Feb 1990 | A |
4932970 | Portney | Jun 1990 | A |
4936666 | Futhey | Jun 1990 | A |
4957506 | Mercier | Sep 1990 | A |
4978211 | Cornu et al. | Dec 1990 | A |
4995714 | Cohen | Feb 1991 | A |
4995715 | Cohen | Feb 1991 | A |
5016977 | Baude et al. | May 1991 | A |
5017000 | Cohen | May 1991 | A |
5019098 | Mercier | May 1991 | A |
5050981 | Roffman | Sep 1991 | A |
5054905 | Cohen | Oct 1991 | A |
5056908 | Cohen | Oct 1991 | A |
5061058 | Guilino et al. | Oct 1991 | A |
5066301 | Wiley | Nov 1991 | A |
5076684 | Simpson et al. | Dec 1991 | A |
5089023 | Swanson | Feb 1992 | A |
5089024 | Christie et al. | Feb 1992 | A |
5096285 | Silberman | Mar 1992 | A |
5100226 | Freeman | Mar 1992 | A |
5104212 | Taboury et al. | Apr 1992 | A |
5112351 | Christie et al. | May 1992 | A |
5114220 | Baude et al. | May 1992 | A |
5116111 | Simpson et al. | May 1992 | A |
5117306 | Cohen | May 1992 | A |
5120120 | Cohen | Jun 1992 | A |
5121979 | Cohen | Jun 1992 | A |
5121980 | Cohen | Jun 1992 | A |
5129718 | Futhey et al. | Jul 1992 | A |
5144483 | Cohen | Sep 1992 | A |
5148205 | Guilino et al. | Sep 1992 | A |
5161057 | Johnson | Nov 1992 | A |
5173723 | Volk et al. | Dec 1992 | A |
5178636 | Silberman | Jan 1993 | A |
5191366 | Kashiwagi | Mar 1993 | A |
5220359 | Roffman | Jun 1993 | A |
5225858 | Portney | Jul 1993 | A |
5229797 | Futhey et al. | Jul 1993 | A |
5236970 | Christ et al. | Aug 1993 | A |
5257132 | Ceglio et al. | Oct 1993 | A |
5260727 | Oksman et al. | Nov 1993 | A |
5322649 | Rheinish et al. | Jun 1994 | A |
5344447 | Swanson | Sep 1994 | A |
5349394 | Freeman et al. | Sep 1994 | A |
5349471 | Morris et al. | Sep 1994 | A |
5381190 | Rehse et al. | Jan 1995 | A |
5384606 | Koch et al. | Jan 1995 | A |
5408281 | Zhang | Apr 1995 | A |
5443506 | Garabet | Aug 1995 | A |
5443507 | Jacobi | Aug 1995 | A |
5444106 | Zhou et al. | Aug 1995 | A |
5446508 | Kitchen | Aug 1995 | A |
5448312 | Roffman et al. | Sep 1995 | A |
5485228 | Roffman et al. | Jan 1996 | A |
5581405 | Meyers et al. | Dec 1996 | A |
5589982 | Faklis et al. | Dec 1996 | A |
5629800 | Hamblen | May 1997 | A |
5652638 | Roffman et al. | Jul 1997 | A |
5674284 | Chang et al. | Oct 1997 | A |
5682223 | Menezes et al. | Oct 1997 | A |
5683457 | Gupta et al. | Nov 1997 | A |
5684560 | Roffman et al. | Nov 1997 | A |
5684595 | Kato et al. | Nov 1997 | A |
5699142 | Lee et al. | Dec 1997 | A |
5715031 | Roffman et al. | Feb 1998 | A |
5715091 | Meyers | Feb 1998 | A |
5724258 | Roffman | Mar 1998 | A |
5728156 | Gupta et al. | Mar 1998 | A |
5748282 | Freeman | May 1998 | A |
5760871 | Kosoburd et al. | Jun 1998 | A |
5777719 | Williams et al. | Jul 1998 | A |
5796462 | Roffman et al. | Aug 1998 | A |
5800532 | Lieberman | Sep 1998 | A |
5805260 | Roffman et al. | Sep 1998 | A |
5822091 | Baker | Oct 1998 | A |
5838496 | Maruyama et al. | Nov 1998 | A |
5847802 | Menezes et al. | Dec 1998 | A |
5888122 | Gupta et al. | Mar 1999 | A |
5895422 | Hauber | Apr 1999 | A |
5895610 | Chang et al. | Apr 1999 | A |
5929969 | Roffman | Jul 1999 | A |
5968094 | Werblin et al. | Oct 1999 | A |
5968095 | Norrby | Oct 1999 | A |
5982543 | Fiala | Nov 1999 | A |
6007747 | Blake et al. | Dec 1999 | A |
6019472 | Koester et al. | Feb 2000 | A |
6050687 | Bille et al. | Apr 2000 | A |
6070980 | Obara et al. | Jun 2000 | A |
6082856 | Dunn et al. | Jul 2000 | A |
6086204 | Magnante | Jul 2000 | A |
6089711 | Blankenbecler et al. | Jul 2000 | A |
6095651 | Williams et al. | Aug 2000 | A |
6120148 | Fiala et al. | Sep 2000 | A |
6126283 | Wen et al. | Oct 2000 | A |
6126286 | Portney | Oct 2000 | A |
6139145 | Israel | Oct 2000 | A |
6142625 | Sawano et al. | Nov 2000 | A |
6145987 | Baude et al. | Nov 2000 | A |
6154323 | Kamo | Nov 2000 | A |
6199986 | Williams et al. | Mar 2001 | B1 |
6210005 | Portney | Apr 2001 | B1 |
6215096 | Von Wallfeld et al. | Apr 2001 | B1 |
6224211 | Gordon | May 2001 | B1 |
6231603 | Lang et al. | May 2001 | B1 |
6270220 | Keren | Aug 2001 | B1 |
6271915 | Frey et al. | Aug 2001 | B1 |
6325510 | Golub et al. | Dec 2001 | B1 |
6338559 | Williams et al. | Jan 2002 | B1 |
6353503 | Spitzer et al. | Mar 2002 | B1 |
6413276 | Werblin | Jul 2002 | B1 |
6429972 | Ota et al. | Aug 2002 | B1 |
6439720 | Graves et al. | Aug 2002 | B1 |
6457826 | Lett | Oct 2002 | B1 |
6462874 | Soskind | Oct 2002 | B1 |
6464355 | Gil | Oct 2002 | B1 |
6474814 | Griffin | Nov 2002 | B1 |
6488708 | Sarfarazi | Dec 2002 | B2 |
6491721 | Freeman et al. | Dec 2002 | B2 |
6497483 | Frey et al. | Dec 2002 | B2 |
6511180 | Guirao et al. | Jan 2003 | B2 |
6520638 | Roffman et al. | Feb 2003 | B1 |
6527389 | Portney | Mar 2003 | B2 |
6533416 | Fermigier et al. | Mar 2003 | B1 |
6536899 | Fiala | Mar 2003 | B1 |
6537317 | Steinert et al. | Mar 2003 | B1 |
6547391 | Ross, III et al. | Apr 2003 | B2 |
6547822 | Lang | Apr 2003 | B1 |
6554425 | Roffman et al. | Apr 2003 | B1 |
6554859 | Lang et al. | Apr 2003 | B1 |
6557992 | Dwyer et al. | May 2003 | B1 |
6576012 | Lang | Jun 2003 | B2 |
6582076 | Roffman et al. | Jun 2003 | B1 |
6585375 | Donitzky et al. | Jul 2003 | B2 |
6609673 | Johnson | Aug 2003 | B1 |
6609793 | Norrby et al. | Aug 2003 | B2 |
6616275 | Dick et al. | Sep 2003 | B1 |
6655802 | Zimmermann et al. | Dec 2003 | B2 |
6685315 | De | Feb 2004 | B1 |
6705729 | Piers et al. | Mar 2004 | B2 |
6709103 | Roffman et al. | Mar 2004 | B1 |
6755524 | Rubinstein et al. | Jun 2004 | B2 |
6791754 | Ogawa | Sep 2004 | B2 |
6802605 | Cox et al. | Oct 2004 | B2 |
6808262 | Chapoy et al. | Oct 2004 | B2 |
6818158 | Pham et al. | Nov 2004 | B2 |
6827444 | Williams et al. | Dec 2004 | B2 |
6830332 | Piers et al. | Dec 2004 | B2 |
6835204 | Stork et al. | Dec 2004 | B1 |
6846326 | Zadno-Azizi et al. | Jan 2005 | B2 |
6848790 | Dick et al. | Feb 2005 | B1 |
6851803 | Wooley et al. | Feb 2005 | B2 |
6884261 | Zadno-Azizi et al. | Apr 2005 | B2 |
6923539 | Simpson et al. | Aug 2005 | B2 |
6923540 | Ye et al. | Aug 2005 | B2 |
6951391 | Morris et al. | Oct 2005 | B2 |
6957891 | Fiala | Oct 2005 | B2 |
6972032 | Aharoni et al. | Dec 2005 | B2 |
6986578 | Jones | Jan 2006 | B2 |
7025456 | Morris et al. | Apr 2006 | B2 |
7036931 | Lindacher et al. | May 2006 | B2 |
7048759 | Bogaert et al. | May 2006 | B2 |
7048760 | Cumming | May 2006 | B2 |
7061693 | Zalevsky | Jun 2006 | B2 |
7073906 | Portney | Jul 2006 | B1 |
7093938 | Morris et al. | Aug 2006 | B2 |
7111938 | Andino et al. | Sep 2006 | B2 |
7137702 | Piers et al. | Nov 2006 | B2 |
7156516 | Morris et al. | Jan 2007 | B2 |
7159983 | Menezes et al. | Jan 2007 | B2 |
7188949 | Bandhauer et al. | Mar 2007 | B2 |
7198640 | Nguyen | Apr 2007 | B2 |
7217375 | Lai | May 2007 | B2 |
7221513 | Cho et al. | May 2007 | B2 |
7232218 | Morris et al. | Jun 2007 | B2 |
7287852 | Fiala | Oct 2007 | B2 |
7293873 | Dai et al. | Nov 2007 | B2 |
7365917 | Zalevsky | Apr 2008 | B2 |
7377640 | Piers et al. | May 2008 | B2 |
7377641 | Piers et al. | May 2008 | B2 |
7441894 | Zhang et al. | Oct 2008 | B2 |
7455404 | Bandhauer et al. | Nov 2008 | B2 |
7475986 | Dai et al. | Jan 2009 | B2 |
7481532 | Hong et al. | Jan 2009 | B2 |
7543937 | Piers et al. | Jun 2009 | B2 |
7572007 | Simpson | Aug 2009 | B2 |
7604350 | Dursteler et al. | Oct 2009 | B2 |
7615073 | Deacon et al. | Nov 2009 | B2 |
7654667 | Blum et al. | Feb 2010 | B2 |
7670371 | Piers et al. | Mar 2010 | B2 |
7677725 | Piers et al. | Mar 2010 | B2 |
7717558 | Hong et al. | May 2010 | B2 |
7753521 | Wooley et al. | Jul 2010 | B2 |
7871162 | Weeber | Jan 2011 | B2 |
7883207 | Iyer et al. | Feb 2011 | B2 |
7896916 | Piers et al. | Mar 2011 | B2 |
7922326 | Bandhauer et al. | Apr 2011 | B2 |
7984990 | Bandhauer et al. | Jul 2011 | B2 |
7998198 | Angelopoulos et al. | Aug 2011 | B2 |
8128222 | Portney | Mar 2012 | B2 |
8157374 | Bandhauer et al. | Apr 2012 | B2 |
8192022 | Zalevsky | Jun 2012 | B2 |
8197063 | Iyer et al. | Jun 2012 | B2 |
8216307 | Schaper, Jr. | Jul 2012 | B2 |
8231219 | Weeber | Jul 2012 | B2 |
8231673 | Sacharoff et al. | Jul 2012 | B2 |
8235525 | Lesage et al. | Aug 2012 | B2 |
8240850 | Apter et al. | Aug 2012 | B2 |
8262728 | Zhang et al. | Sep 2012 | B2 |
8292953 | Weeber et al. | Oct 2012 | B2 |
8382281 | Weeber | Feb 2013 | B2 |
8388137 | Dreher et al. | Mar 2013 | B2 |
8444267 | Weeber et al. | May 2013 | B2 |
8480228 | Weeber | Jul 2013 | B2 |
8500805 | Kobayashi et al. | Aug 2013 | B2 |
8506075 | Bandhauer et al. | Aug 2013 | B2 |
8529623 | Piers et al. | Sep 2013 | B2 |
8556416 | Lawu | Oct 2013 | B2 |
8556417 | Das et al. | Oct 2013 | B2 |
8573775 | Weeber | Nov 2013 | B2 |
8619362 | Portney | Dec 2013 | B2 |
8636796 | Houbrechts et al. | Jan 2014 | B2 |
8652205 | Hong et al. | Feb 2014 | B2 |
8678583 | Cohen | Mar 2014 | B2 |
8709079 | Zhang et al. | Apr 2014 | B2 |
8734511 | Weeber et al. | May 2014 | B2 |
8740978 | Weeber et al. | Jun 2014 | B2 |
8747466 | Weeber et al. | Jun 2014 | B2 |
8755117 | Kobayashi et al. | Jun 2014 | B2 |
8771348 | Zhao | Jul 2014 | B2 |
8827446 | Iyer et al. | Sep 2014 | B2 |
8906089 | Piers et al. | Dec 2014 | B2 |
9069185 | Zhao | Jun 2015 | B2 |
9078745 | Zhang et al. | Jul 2015 | B2 |
9122074 | Piers et al. | Sep 2015 | B2 |
9164201 | Fermigier et al. | Oct 2015 | B2 |
9223148 | Fiala et al. | Dec 2015 | B2 |
9304329 | Zhao | Apr 2016 | B2 |
9310624 | Argal et al. | Apr 2016 | B2 |
9320594 | Schwiegerling | Apr 2016 | B2 |
9329309 | Van | May 2016 | B2 |
9335563 | Weeber | May 2016 | B2 |
9335564 | Choi et al. | May 2016 | B2 |
9370416 | Argal et al. | Jun 2016 | B2 |
9518864 | Grossinger et al. | Dec 2016 | B2 |
9563070 | Ando et al. | Feb 2017 | B2 |
9622856 | Weeber et al. | Apr 2017 | B2 |
9869580 | Grossinger et al. | Jan 2018 | B2 |
9925041 | Gerlach et al. | Mar 2018 | B2 |
20010018612 | Carson et al. | Aug 2001 | A1 |
20020082690 | Sarbadhikari | Jun 2002 | A1 |
20020093701 | Zhang et al. | Jul 2002 | A1 |
20020118337 | Perrott et al. | Aug 2002 | A1 |
20030014107 | Reynard | Jan 2003 | A1 |
20030076478 | Cox | Apr 2003 | A1 |
20030169491 | Bender et al. | Sep 2003 | A1 |
20030171808 | Phillips | Sep 2003 | A1 |
20040085515 | Roffman et al. | May 2004 | A1 |
20040088050 | Norrby et al. | May 2004 | A1 |
20040106992 | Lang et al. | Jun 2004 | A1 |
20040111153 | Woods et al. | Jun 2004 | A1 |
20040189981 | Ross et al. | Sep 2004 | A1 |
20050096226 | Stock et al. | May 2005 | A1 |
20050099589 | Ishak | May 2005 | A1 |
20050128432 | Altmann | Jun 2005 | A1 |
20050203619 | Altmann | Sep 2005 | A1 |
20050259222 | Kelch et al. | Nov 2005 | A1 |
20050267575 | Nguyen et al. | Dec 2005 | A1 |
20060004446 | Aharoni et al. | Jan 2006 | A1 |
20060009816 | Fang et al. | Jan 2006 | A1 |
20060030938 | Altmann | Feb 2006 | A1 |
20060066808 | Blum et al. | Mar 2006 | A1 |
20060109421 | Ye et al. | May 2006 | A1 |
20060116763 | Simpson | Jun 2006 | A1 |
20060116764 | Simpson | Jun 2006 | A1 |
20060139570 | Blum et al. | Jun 2006 | A1 |
20060238702 | Glick et al. | Oct 2006 | A1 |
20060244904 | Hong et al. | Nov 2006 | A1 |
20070052920 | Stewart et al. | Mar 2007 | A1 |
20070129803 | Cumming et al. | Jun 2007 | A1 |
20070171362 | Simpson et al. | Jul 2007 | A1 |
20070258143 | Portney | Nov 2007 | A1 |
20070268451 | Raghuprasad | Nov 2007 | A1 |
20070282438 | Hong et al. | Dec 2007 | A1 |
20080147185 | Hong et al. | Jun 2008 | A1 |
20080161913 | Brady et al. | Jul 2008 | A1 |
20080161914 | Brady et al. | Jul 2008 | A1 |
20080269891 | Hong et al. | Oct 2008 | A1 |
20080273169 | Blum et al. | Nov 2008 | A1 |
20080300679 | Altmann | Dec 2008 | A1 |
20090062911 | Bogaert | Mar 2009 | A1 |
20090088840 | Simpson et al. | Apr 2009 | A1 |
20090164008 | Hong et al. | Jun 2009 | A1 |
20090210054 | Weeber et al. | Aug 2009 | A1 |
20090240328 | Treushnikov et al. | Sep 2009 | A1 |
20090295295 | Shannon et al. | Dec 2009 | A1 |
20090323020 | Zhao et al. | Dec 2009 | A1 |
20100016961 | Hong et al. | Jan 2010 | A1 |
20100057202 | Bogaert | Mar 2010 | A1 |
20100087921 | Simpson | Apr 2010 | A1 |
20100131060 | Simpson et al. | May 2010 | A1 |
20100161051 | Hong | Jun 2010 | A1 |
20100274233 | Dick et al. | Oct 2010 | A1 |
20100281021 | Weeber et al. | Nov 2010 | A1 |
20100312336 | Hong et al. | Dec 2010 | A1 |
20110022170 | Simpson et al. | Jan 2011 | A1 |
20110109874 | Piers et al. | May 2011 | A1 |
20110125261 | Portney | May 2011 | A1 |
20110149236 | Weeber | Jun 2011 | A1 |
20110166652 | Bogaert et al. | Jul 2011 | A1 |
20110270596 | Weeber | Nov 2011 | A1 |
20110313522 | Hayes | Dec 2011 | A1 |
20110313523 | Hayes | Dec 2011 | A1 |
20110313525 | Cumming | Dec 2011 | A1 |
20120059464 | Zhao | Mar 2012 | A1 |
20120140166 | Zhao | Jun 2012 | A1 |
20120143326 | Canovas et al. | Jun 2012 | A1 |
20120154740 | Bradley et al. | Jun 2012 | A1 |
20120170121 | Okada et al. | Jul 2012 | A1 |
20120320335 | Weeber et al. | Dec 2012 | A1 |
20120323321 | Simonov et al. | Dec 2012 | A1 |
20130035760 | Portney | Feb 2013 | A1 |
20130046381 | Zalevsky et al. | Feb 2013 | A1 |
20130060330 | Weeber et al. | Mar 2013 | A1 |
20130107202 | Liang | May 2013 | A1 |
20150022775 | Ando et al. | Jan 2015 | A1 |
20150029460 | Bradley et al. | Jan 2015 | A1 |
20150094807 | Piers et al. | Apr 2015 | A1 |
20150359625 | Argal et al. | Dec 2015 | A1 |
20160216535 | Zhao | Jul 2016 | A1 |
20160220350 | Gerlach | Aug 2016 | A1 |
20160220352 | Choi et al. | Aug 2016 | A1 |
20160320633 | Weeber et al. | Nov 2016 | A1 |
20160334640 | De, Jr. et al. | Nov 2016 | A1 |
20160341978 | Schwiegerling | Nov 2016 | A1 |
20170209259 | Choi et al. | Jul 2017 | A1 |
20170216020 | Weeber et al. | Aug 2017 | A1 |
20170219846 | Ando | Aug 2017 | A1 |
20170227789 | Ando et al. | Aug 2017 | A1 |
20170239038 | Choi et al. | Aug 2017 | A1 |
20170245985 | Canovas et al. | Aug 2017 | A1 |
20170245986 | Canovas Vidal et al. | Aug 2017 | A1 |
20170245987 | Canovas et al. | Aug 2017 | A1 |
20170252151 | Mackool | Sep 2017 | A1 |
20180092739 | Pagnoulle et al. | Apr 2018 | A1 |
20180132996 | Tiwari et al. | May 2018 | A1 |
20180147050 | Choi et al. | May 2018 | A1 |
20180147052 | Hong et al. | May 2018 | A1 |
20180275428 | Ando | Sep 2018 | A1 |
20180368972 | Rosen | Dec 2018 | A1 |
20180373060 | Knox et al. | Dec 2018 | A1 |
20190224000 | Choi et al. | Jul 2019 | A1 |
20190254810 | Tiwari et al. | Aug 2019 | A1 |
20190307557 | De Carvalho et al. | Oct 2019 | A1 |
20190314148 | Liu | Oct 2019 | A1 |
20200038172 | Hussain et al. | Feb 2020 | A1 |
20210294123 | Weeber et al. | Sep 2021 | A1 |
Number | Date | Country |
---|---|---|
2005230194 | Dec 2010 | AU |
2501217 | Apr 2004 | CA |
2507659 | Jun 2004 | CA |
2590085 | Jun 2006 | CA |
1951340 | Apr 2007 | CN |
104918580 | Sep 2015 | CN |
108646434 | Oct 2018 | CN |
335731 | Oct 1989 | EP |
342895 | Nov 1989 | EP |
0369561 | May 1990 | EP |
375291 | Jun 1990 | EP |
412751 | Feb 1991 | EP |
0457553 | Nov 1991 | EP |
470811 | Feb 1992 | EP |
605841 | Jul 1994 | EP |
0316162 | Oct 1995 | EP |
355230 | Oct 1995 | EP |
681198 | Nov 1995 | EP |
0537643 | Mar 1997 | EP |
949529 | Oct 1999 | EP |
1376203 | Jan 2004 | EP |
1862148 | Dec 2007 | EP |
1310267 | Jan 2008 | EP |
1891912 | Feb 2008 | EP |
2043558 | Apr 2009 | EP |
2045648 | Apr 2009 | EP |
1402308 | May 2009 | EP |
1424049 | Jun 2009 | EP |
2103279 | Sep 2009 | EP |
2113226 | Nov 2009 | EP |
2365379 | Sep 2011 | EP |
2377493 | Oct 2011 | EP |
2378319 | Oct 2011 | EP |
2290411 | May 2012 | EP |
2363097 | Sep 2012 | EP |
2812882 | Dec 2014 | EP |
2813881 | Dec 2014 | EP |
2349093 | Oct 2015 | EP |
3179293 | Jun 2017 | EP |
3150170 | Dec 2017 | EP |
3415980 | Dec 2018 | EP |
2527908 | Mar 2019 | EP |
1215851 | Feb 1990 | IT |
1154119 | Jun 1989 | JP |
2028615 | Jan 1990 | JP |
2079815 | Mar 1990 | JP |
2137814 | May 1990 | JP |
2249631 | Oct 1990 | JP |
3011315 | Jan 1991 | JP |
2013101323 | May 2013 | JP |
101154066 | Jun 2012 | KR |
9002963 | Mar 1990 | WO |
9222264 | Dec 1992 | WO |
9303409 | Feb 1993 | WO |
9413225 | Jun 1994 | WO |
9417435 | Aug 1994 | WO |
9724639 | Jul 1997 | WO |
9744689 | Nov 1997 | WO |
9831299 | Jul 1998 | WO |
9907309 | Feb 1999 | WO |
9923526 | May 1999 | WO |
0019906 | Apr 2000 | WO |
0076426 | Dec 2000 | WO |
0121061 | Mar 2001 | WO |
0163344 | Aug 2001 | WO |
0182839 | Nov 2001 | WO |
0189424 | Nov 2001 | WO |
0221194 | Mar 2002 | WO |
0234158 | May 2002 | WO |
02084381 | Oct 2002 | WO |
02088830 | Nov 2002 | WO |
03009053 | Jan 2003 | WO |
2004013680 | Feb 2004 | WO |
2004034129 | Apr 2004 | WO |
2004049979 | Jun 2004 | WO |
2004090611 | Oct 2004 | WO |
2004096014 | Nov 2004 | WO |
2004113959 | Dec 2004 | WO |
05019906 | Mar 2005 | WO |
06025726 | Mar 2006 | WO |
2006047698 | May 2006 | WO |
06060477 | Jun 2006 | WO |
2006060480 | Jun 2006 | WO |
2006067255 | Jun 2006 | WO |
2007092948 | Aug 2007 | WO |
2007133384 | Nov 2007 | WO |
2008045847 | Apr 2008 | WO |
2008150982 | Dec 2008 | WO |
2009017403 | Feb 2009 | WO |
2009027438 | Mar 2009 | WO |
2009043985 | Apr 2009 | WO |
2009058755 | May 2009 | WO |
2009076670 | Jun 2009 | WO |
2009130610 | Oct 2009 | WO |
2009148454 | Dec 2009 | WO |
2010046356 | Apr 2010 | WO |
2010054255 | May 2010 | WO |
2010059764 | May 2010 | WO |
2010079528 | Jul 2010 | WO |
2010093975 | Aug 2010 | WO |
2010100523 | Sep 2010 | WO |
2010104530 | Sep 2010 | WO |
2010144315 | Dec 2010 | WO |
2011024125 | Mar 2011 | WO |
2011055228 | May 2011 | WO |
2011075641 | Jun 2011 | WO |
2011075668 | Jun 2011 | WO |
2012004746 | Jan 2012 | WO |
2012031211 | Mar 2012 | WO |
2012070313 | May 2012 | WO |
2012078763 | Jun 2012 | WO |
2012085917 | Jun 2012 | WO |
2012122411 | Sep 2012 | WO |
2012140389 | Oct 2012 | WO |
2013018379 | Feb 2013 | WO |
2013028992 | Feb 2013 | WO |
2013093916 | Jun 2013 | WO |
2013114209 | Aug 2013 | WO |
2013116133 | Aug 2013 | WO |
2013118177 | Aug 2013 | WO |
2013118499 | Aug 2013 | WO |
2014008343 | Jan 2014 | WO |
2014033543 | Mar 2014 | WO |
2014091528 | Jun 2014 | WO |
2014111831 | Jul 2014 | WO |
2014189049 | Nov 2014 | WO |
2017137841 | Aug 2017 | WO |
2017149403 | Sep 2017 | WO |
2018093873 | May 2018 | WO |
2018150236 | Aug 2018 | WO |
2019002384 | Jan 2019 | WO |
2019130030 | Jul 2019 | WO |
2020115104 | Jun 2020 | WO |
Entry |
---|
International Search Report and Written Opinion for Application No. PCT/EP2019/083615, dated Mar. 17, 2020, 14 pages. |
Morlock, R., et al., “Patient-Reported Spectacle Independence Questionnaire (PRSIQ): Development and Validation,” American Journal of Ophthalmology, Jun. 2017, vol. 178, pp. 101-114. |
Albert D.M., “(Book Review) Intraocular Lenses: Evolution, Designs, Complications, and Pathology, by David Apple et al.,” Archieves of Opthalmology, 1990, vol. 108, pp. 650. |
Alfonso J.F., et al., “Prospective Study of the Acri.LISA Bifocal Intraocular Lens,” Journal of Cataract Refractive Surgery, Nov. 2007, vol. 33 (11), pp. 1930-1935. |
Alvarez S. L. et al., “Spectral threshold: measurement and clinical applications,” British Journal of Ophthalmology, 1983, 67, 504-507. |
Apple D. J., et al., Eds., “Intraocular Lenses: Evolution, Designs, Complications and Pathology,” in: New Concepts in Intraocular Lens Implantation, Williams & Wilkins publisher, Jan. 1989, vol. 22 (36), pp. 205-221. |
Apple D.J., et al., Eds., “Intraocular Lenses: Evolution, Designs, Complications and Pathology,” in: New Concepts in Intraocular Lens Implantation, Williams & Wilkins publisher, Jan. 1989, vol. 36 (1), pp. 21-36. |
Artal P., et al., “Contributions of the Cornea and the Lens to the Aberrations of the Human Eye,” Optics Letters, 1998, vol. 23 (21), pp. 1713-1715. |
Atchinson D.A., “Design of Aspheric Intraocular Lens,” Ophthamic & Physiological Optics, 1991, vol. 11 (2), pp. 137-146. |
Atchinson D.A., et al., “Optical Design of Intraocular Lenses. II. Off-Axis performance,” Optometry & Vision Science, 1989, vol. 66 (9), pp. 579-590. |
Atchinson D.A., et al., “Third-Order Aberrations Of Pseudophakic Eyes,” Ophthalmic and Physiological Optics, 1989, vol. 9, pp. 205-211. |
Atchinson D.A., “Optical Design of Intraocular Lenses. I. On-Axis Performance,” American Academy of Optometry, 1989, vol. 66 (8), pp. 492-506. |
Atchinson D.A., “Optical design of intraocular lenses III. On-Axis Performance in the Presence of Lens Displacement,” American Academy of Optometry, 1989, vol. 66 (10), pp. 671-681. |
Atchinson, “Refractive errors induced by displacement of intraocular lenses within the pseudophakic eye,” Optometry & Vision Science, 1989, 66 (3), 146-152. |
Bonnet R., et al., “New Method Of Topographical Ophthalmometry—Its Theoretical And Clinical Applications,” American Journal of Optometry, 1962, vol. 39 (5), pp. 227-251. |
Bradley A. et al., “Achromatizing the Human Eye” Optometry & Vision Science, 1991, vol. 68 (8), pp. 608-616. |
Buralli D.A., et al., “Optical Performance Of Holographic Kinoforms,” Applied Optics, Mar. 1989, vol. 28 (5), pp. 976-983. |
Canovas C., et al., “Hybrid Adaptive-Optics Visual Simulator,” Optical Letters, Jan. 15, 2010, vol. 35 (2), pp. 196-198. |
Castignoles F., et al., “Comparison of the Efficiency, MTF and Chromatic Properties of Four Diffractive Bifocal Intraocular Lens Designs, ” Optics Express, Mar. 2010, vol. 18 (5), pp. 5245-5256. |
Cohen A.L., “Diffractive Bifocal Lens Design,” Optometry and Vision Science, Jun. 1993, vol. 70 (6), pp. 461-468. |
Cohen A.L., “Practical Design of a Bifocal Hologram Contact Lens or Intraocular Lens,” Applied Optics, Jul. 1, 1992, vol. 31 (19), pp. 3750-3754. |
Diffractive Lenses for Extended Depth of Focus and Presbyopic Correction, Presentation from Wavefront Congress field on Feb. 15, 2008, Rochester, New York. |
Doskolovich L.L., et al., “Special Diffractive Lenses,” Lens and Optical Systems Design, Apr. 1992, vol. 1780, pp. 393-402. |
Dwyer W. O. et al., “Racial Differences In Color Vision: Do They Exist”, American Journal of Optometry & Physiological Optics, 1975, 52, 224-229. |
El Hage S.G., et al., “Contribution of the Crystalline Lens to the Spherical Aberration of the Eye,” 1973, vol. 63 (2), pp. 205-211. |
Futhey J.A., “Diffractive Bifocal Intraocular Lens,” SPIE, 1989, vol. 1052, pp. 142-148. |
Geun Y., et al., “Visual Performance after Correcting the Monchromatic and Chromatic Aberrations of the Eye,” Journal of the Optical Society of America, 2002, vol. 19 (2), pp. 266-275. |
Glasser A. et al., “Presbyopia and the optical changes in the human crystalline lens with age,” Vision Res, 1998, 38 (2), 209-229. |
Greivenkamp J.E., et al., “Visual Acuity Modeling Using Optical Raytracing Of Schematic Eyes,” American Journal of Ophthalmology, 1995, vol. 120 (2), pp. 227-240. |
Griswold Scott et al., “Scotopic Spectral Sensitivity of Phakic and Aphakic Observers Extending into the Near Ultraviolet,” Vision res, 1992, 32 (9), 1739-1743. |
Guirao A., et al., “Corneal Wave Aberration from Videokeratography: Accuracy And Limitations of the Procedure,” Journal of the Optical Society of America, 2000, vol. 17 (6), pp. 955-965. |
IOVS, 1999, 40 (4), S535. |
Kiely et al., “The mean shape of the human cornea,” Optica ACTA, 1982, 29 (8), 1027-1040. |
Kokoschka S., et al., “Influence of Field Size on the Spectral Sensitivity of the Eye in the Photopic and Mesopic Range,” American Journal of Optometry and Physiological Optics, 1985, vol. 62 (2), pp. 119-126. |
Liang J., et al., “Objective Measurement Of Wave Aberrations Of The Human Eye With The Use Of A Hartmann-Shack Wave-Front Sensor,” Journal of the Optical Society of America, 1994, vol. 11 (7), pp. 1949-1957. |
Lindsay R., et al., “Descriptors of Corneal Shape,” Optometry and Vision Science, 1998, vol. 75 (2), pp. 156-158. |
Liou H.L., et al., “Anatomically Accurate, Finite Model Eye for Optical Modeling,” Journal of Optical Society of America, Aug. 1997, vol. 14 (8), pp. 1684-1695. |
Lotmar, “Theoretical eye model with aspherics,” Journal of the Optical Society of America, 1971, 61 (11), 1522-1529. |
Malacara D., et al., “Wavefront Fitting With Discrete Orthogonal Polynomials In a Unit Radius Circle,” Optical Engineering, 1990, vol. 29 (6), pp. 672-675. |
Mandell R.B., et al., “Mathematical Model of the Corneal Contour,” 1965, School of Optometry, University of California, Berkeley, pp. 183-197. |
Marcos S., et al., “A New Approach to the Study of Ocular Chromatic Aberrations,” Vision Research, 1999, vol. 39 (26), pp. 4309-4323. |
Marsack J.D., et al., “Metrics of Optical Quality Derived from Wave Aberrations Predict Visual Performance,” Journal of Vision, Apr. 2004, vol. 4 (4), pp. 322-328. |
Monsoriu J.A., et al., “Devil's Lenses,” Optics Express, Oct. 17, 2007, vol. 15 (21), pp. 13858-13864. |
Mordi J.A., et al., “Influence of Age of Chromatic Aberration of the Human Eye,” American Journal of Optometry & Physiological Optics, 1985, vol. 62 (12), pp. 864-869. |
Navarro R., et al., “Accommodation-Dependent Model of the Human Eye with Aspherics,” Journal of the Optical Society of America, Aug. 1985, vol. 2 (8), pp. 1273-1281. |
Norrby S., et al., “Model Eyes for Evaluation of Intraocular Lenses,” Applied Optics, Sep. 7, 2007, vol. 46 (26), pp. 6595-6605. |
“Optical Design,” Military Standardization Handbook, 1962, Chapter 4, U.S. Department of Defense MIL-HDBK-141, 4-1-4-19. |
Oshika T., et al., “Changes in Corneal Wavefront Aberrations with Aging,” Investigative Ophthalmology & Visual Science, 1999, vol. 40 (7), pp. 1351-1355. |
Patel S., et al., “Shape and Radius of Posterior Corneal Surface,” Refractive and Corneal Surgery, 1993, vol. 9 (3), pp. 173-181. |
Piers P.A.., et al., “Eye Models for the Prediction of Contrast Vision in Patients with New Intraocular Lens Designs,” Optics Letters, Apr. 1, 2004, vol. 29 (7), pp. 733-735. |
Piers P.A., et al., “Theoretical Comparison of Aberration-Correcting Customized and Aspheric Intraocular Lenses,” Journal of Refractive Surgery, Apr. 2007, vol. 23 (4), pp. 374-384. |
Said et al., “The Variation with Age of the Spectral Transmissivity of the Living Human Crystalline Lens,” Gerontologia, 1959, 213-231. |
Schwiegerling et al., “Representation of videokeratoscopic height data with Zemike polynomials,” Journal of the Optical Society of America, 1995, 12 (10), 2105-2113. |
Seitz B., et al., “Corneal Topography,” Current Opinion in Ophthalmolgy, 1997, vol. 8 (4), pp. 8-24. |
Siedlecki D., et al., “Radial Gradient index Intraocular Lens: a Theoretical Model,” Journal of Modern Optics, Feb. 20-Mar. 10, 2008, vol. 55 (4-5), pp. 639-647. |
Smith G., et al., “The Spherical Aberration of the Crystalline Lens of the Human Eye,” Vision Res., 2001, vol. 41 (2), pp. 235-243. |
Smith Kinney, “Sensitivity of the eye to spectral radiation at scotopic and mesopic intensity levels,” Journal of the Optical Society of America, 1955,45 (7), 507-514. |
Sokołowski M., et al. “Hybrid Heptafocal Intraocular Lenses, ” Optica Applicata, Dec. 2015, vol. 45 (3), pp. 285-298. |
Terwee T., et al., “Visualization of the Retinal Image in an Eye Model With Spherical and Aspheric, Diffractive, and Refractive Multifocal Intraocular Lenses,” Journal of Refractive Surgery, Mar. 2008, vol. 24 (3), pp. 223-232. |
Thibos L. N. et al., “The chromatic eye: a new reduced-eye model of ocular chromatic aberration in humans,” Applied Optics, 1992, 31 (19), 3594-3600. |
Thibos L. N. et al., “Theork and measurement of ocular chromatic aberration,” Vision Res, 1988, 30 (1), 33-49. |
Townsley, “New Knowledge of the corneal contour,” Contacto, 1970, pp. 38-43. |
Van Den Berg T.J., “Analysis of Intraocular Straylight, Especially in Relation to Age,” Optometry and Vision Science, Feb. 1995, vol. 72 (2), pp. 52-59. |
Van Meeteren A., “Calculations on the Optical Modulation Transfer Function of the Human Eye for White Light,” Optica Acta, May 1974, vol. 21 (5), pp. 395-412. |
Verriest G., “The Spectral Curve of Relative Luminous Efficiency in Different Age Groups of Aphakic Eyes,” Mod Probl Ophthalmol., 1974, 13, 314-317. |
Villegas E.A., et al., “Correlation between Optical and Psychophy, Sical Parameters as a Function of Defocus,” Optometry and Vision Science, Jan. 1, 2002, vol. 79 (1), pp. 60-67. |
Wang J.Y., et al., “Wave-Front Interpretation With Zemike Polynomials,” Applied Optics, 1980, vol. 19 (9), pp. 1510-1518. |
Number | Date | Country | |
---|---|---|---|
20210196452 A1 | Jul 2021 | US |
Number | Date | Country | |
---|---|---|---|
62955355 | Dec 2019 | US |